These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 10519427)

  • 1. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
    Sebire NJ; Snijders RJ; Hughes K; Sepulveda W; Nicolaides KH
    Br J Obstet Gynaecol; 1996 Oct; 103(10):999-1003. PubMed ID: 8863698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
    Pandya PP; Snijders RJ; Johnson SP; De Lourdes Brizot M; Nicolaides KH
    Br J Obstet Gynaecol; 1995 Dec; 102(12):957-62. PubMed ID: 8652486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
    Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
    Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
    Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
    Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
    Chasen ST; Sharma G; Kalish RB; Chervenak FA
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
    Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
    Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
    Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
    Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first trimester combined test for aneuploidies - a single center experience.
    Veduta A; Vayna AM; Duta S; Panaitescu A; Popescu F; Bari M; Peltecu G; Nedelea F
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2091-2096. PubMed ID: 28553771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester fetal nuchal translucency: problems with screening the general population. 2.
    Bewley S; Roberts LJ; Mackinson AM; Rodeck CH
    Br J Obstet Gynaecol; 1995 May; 102(5):386-8. PubMed ID: 7612532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.